IBN trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes IBN achieves its forward estimates and maintains a stable P/E multiple of 0.2x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, ICICI Bank Limited (IBN) has a Wall Street consensus price target of N/A, based on estimates from 6 covering analysts. The company has a market capitalization of $101.13B.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, IBN trades at a trailing P/E of 17.9x and forward P/E of 0.2x. The forward PEG ratio of 0.01 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -5.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $2730.03, with bear and bull scenarios of $1719.92 and $3597.09 respectively. Model confidence stands at 54/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HDBHDFC Bank Limited | $116.9B | $22.79 | — | — | Hold | 0.2x | 6 |
 ITUBItaú Unibanco Holding S.A. | $90.2B | $8.18 | $6.38 | -22.0% | Buy | 1.8x | 13 |
 BBDBanco Bradesco S.A. | $36.6B | $3.46 | $3.20 | -7.5% | Hold | 1.3x | 16 |
 KBKB Financial Group Inc. | $44.0B | $125.39 | — | — | Hold | 0.0x | 6 |
 SHGShinhan Financial Group Co., Ltd. | $37.7B | $79.83 | — | — | Buy | 0.0x | 2 |
 BACBank of America Corporation | $397.4B | $56.00 | $66.00 | +17.9% | Buy | 12.1x | 54 |
 CCitigroup Inc. | $226.3B | $131.96 | $150.18 | +13.8% | Buy | 11.8x | 27 |
 JPMJPMorgan Chase & Co. | $904.4B | $337.53 | $373.64 | +10.7% | Buy | 13.6x | 61 |
 HSBCHSBC Holdings plc | $344.5B | $100.25 | $52.00 | -48.1% | Hold | 11.8x | 21 |
 BCSBarclays PLC | $81.9B | $24.29 | $58.00 | +138.8% | Buy | 8.6x | 25 |
Quick answers to the most common questions about buying IBN stock.
The consensus price target for IBN is $N/A, close to the current price of $27.91 (N/A% implied move). Based on 6 analyst estimates, the stock appears fairly valued near current levels.
IBN has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
With a forward P/E of 0.1978x, IBN trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $N/A for IBN, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $3597 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
IBN is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month IBN stock forecast based on 6 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $2730, with bear/bull scenarios of $1720/$3597.
Our quantitative valuation model calculates IBN's fair value at $2730 (base case), with a bear case of $1720 and bull case of $3597. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 54/100.
IBN trades at a forward P/E ratio of 0.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 17.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
IBN appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
IBN analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $1720-$3597 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.